Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Galanin receptor 3 - A new pharmacological target in retina degeneration.

Pharmacological research - 1 Feb 2023

Ortega Joseph T, Parmar Tanu, Jastrzebska Beata

Abstract excerpt

The neuropeptide galanin receptor 3 (GALR3) is a class A G protein-coupled receptor (GPCR) broadly expressed in the nervous system, including the retina. GALR3 is involved in the modulation of immune and inflammatory responses. Tight control of these processes is critical for maintaining homeostasis in the retina and is required to sustain vision. Here, we investigated the role of GALR3 in retina pathologies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP-Binding Cassette Transporters
Share to Disease Models, Animal
Share to Mice

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Retina

Share to Retinal Degeneration

Share to Retinitis Pigmentosa

Source

Open in PubMed Open full text

Identifiers

PMID: 36693600
DOI: 10.1016/j.phrs.2023.106675
PMCID: PMC9918719

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Galanin receptor 3 - A new pharmacological target in retina degeneration.PMID 36693600Read ↗

Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa.Semantic proximity Read ↗

Mechanisms of Rhodopsin-Related Inherited Retinal Degeneration and Pharmacological Treatment StrategiesSemantic proximity Read ↗

Rhodopsin-associated retinal dystrophy: Disease mechanisms and therapeutic strategiesSemantic proximity Read ↗

Cell Death Pathways in Mutant Rhodopsin Rat Models Identifies Genotype-Specific Targets Controlling Retinal Degeneration.Semantic proximity Read ↗

Flavonoids improve the stability and function of P23H rhodopsin slowing down the progression of retinitis pigmentosa in mice.Semantic proximity Read ↗

[New drug therapy for retinal degeneration].Semantic proximity Read ↗

Enhanced Endocytosis and Mitochondrial Stress Underlie Severe Retinitis Pigmentosa With RHO P347L Mutant.Semantic proximity Read ↗

Loss of αA or αB-Crystallin Accelerates Photoreceptor Cell Death in a Mouse Model of P23H Autosomal Dominant Retinitis Pigmentosa.Semantic proximity Read ↗

Rhodopsin homeostasis and retinal degeneration: lessons from the fly.Semantic proximity Read ↗

Acute Stress Responses Are Early Molecular Events of Retinal Degeneration in<i>Abca4<sup>−/−</sup>Rdh8<sup>−/−</sup></i>Mice After Light ExposureSemantic proximity Read ↗

Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degenerationSemantic proximity Read ↗

MicroRNA-223 Regulates Retinal Function and Inflammation in the Healthy and Degenerating RetinaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.